Kyntra Bio, Inc. Common Stock

KYNBNASDAQ • USD
2.27 USD
↘ 0.93 (28.90%)🟢LIVE (AS OF 11:22 AM EST)
🟢Market: OPEN

Kyntra Bio, Inc. Common Stock (KYNB) trades at $2.27 per share. Technical indicators currently signal "Strong Sell". Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, KYNB appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$2.33
High?$3.03
Low?$2.02
Prev. Close?$3.20
Volume?124.4K
Avg. Volume?23.7K
VWAP?$2.24
Rel. Volume?5.26x
Bid / Ask
Bid?$1.82 × 100
Ask?$2.26 × 100
Spread?$0.44
Midpoint?$2.04
Valuation & Ratios
Market Cap?13.0M
Shares Out?4.0M
Float?3.9M
Float %?95.7%
P/E Ratio?0.07
P/B Ratio?-0.43
EPS?$45.24
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.
Employees
34
Market Cap
13.0M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2014-11-14
Address
350 BAY STREET
SAN FRANCISCO, CA 94133
Phone: 415-978-1200
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestModerate
Short % of Float?2.47%Low
Short Interest?95.8K
Days to Cover?4.7
Free Float3.9M
Avg Daily Volume20.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?2.69Strong
Quick Ratio?2.59Strong
Cash Ratio?1.41Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
Peers
100
S&P
97
0.1CHEAP▾
P/B?
S&P
97
-0.43CHEAP▾
P/S?
Peers
100
S&P
53
2.81CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.8CHEAP▾
EV/Sales?
S&P
97
-8.16CHEAP▾
Returns & Efficiency
ROE?
S&P
3
-607.7%WEAK▾
ROA?
Peers
50
S&P
97
181.2%STRONG▾
Cash Flow & Enterprise
FCF?$-38062000
Enterprise Value?$-37686803
Fundamentals ratios updated end of day